Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 4 institutions in 1 country.
Brandon C RosenMedical Scientist Training Program, University of Miami Miller School of Medicine, Miami, FL, United States.
Nuria Pedreño-LopezDepartment of Pathology, George Washington University School of Medicine, Washington, DC, United States.
Michael J RicciardiDepartment of Pathology, George Washington University School of Medicine, Washington, DC, United States.
Jason S ReedVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Jonah B SachaVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Eva G RakaszWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, United States.
David I WatkinsDepartment of Pathology, George Washington University School of Medicine, Washington, DC, United States.
George Washington University · USChildren's Cancer Therapy Development Institute · USUniversity of Miami · USUniversity of Wisconsin–Madison · US
Funding
WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
Yellow Fever Vector Development P01AI094420 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BONALDO, MYRNA C · 2012 to 2016
$11.4M
The Functional Significance of Cytotoxic T Lymphocyte EscapeR01AI052056 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2003 to 2024
$8.3M
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?R01AI108421 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WATKINS, DAVID I · 2014 to 2018
$2.9M
Retargeting cytotoxic T lymphocytes in HIV/SIV infection to kill infected cellsF30AI147881 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROSEN, BRANDON C · 2019 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Rhesus Cytomegalovirus-Specific CD8 · full record | OpenQuestion